Breast cancer: suggested protocol guidelines for combination chemotherapy trials and for combined modality trials
U.S. Dept. of Health, Education, and Welfare, Public Health Service - Health & Fitness - 35 pages
What people are saying - Write a review
We haven't found any reviews in the usual places.
5X Upper limit Alkaline Phosphatase and/or Bilirubin biopsy bone scans Breast Cancer Breast Cancer Task Cancer Task Force carci carcinoma clinical Contralateral Breast cytology defined Duration of Response Eligibility and Workup evaluation followup groups guidelines Hematologic hematuria Hepatic Hepatic Toxicity Histopathology hormone interval ldentification least 4 weeks lesions Leukopenia limit of normal liver liver function tests Liver scan lnclusive Dates lndica lnfiltrating lntolerable lumbar puncture Lymph Nodes M.D. William menopausal ment metastatic metastatic disease ml/min morbid events Neutropenia noma Non-infiltrating Normal values number of patients Oophorectomy opsy organ overall objective response param parameters Paresthesias Pathologic Peripheral Neuropathy Pleural Effusion positive bone scans positive cytology Pretreatment Workup Primary Breast protocol study randomized regimen Renal reported Serum creatinine specified status Stephen Carter stratification Study Data Suspicious Therapeutic morbidity Therapy Death Thrombopenia tient tion TNM system Toxicity Grade treatment failure Tumor Tumor Response UlCC-AJC utilized Vomiting